WOOJUNG BIO, Inc. (KOSDAQ:215380)

Market Cap	27.95B
Revenue (ttm)	49.14B
Net Income (ttm)	2.89B
Shares Out	16.83M
EPS (ttm)	12.04
PE Ratio	137.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,991
Average Volume	59,076
Open	1,676.00
Previous Close	1,676.00
Day's Range	1,642.00 - 1,690.00
52-Week Range	1,100.00 - 4,300.00
Beta	0.66
RSI	45.40
Earnings Date	n/a

About WOOJUNG BIO

WOOJUNG BIO, Inc. provides non-clinical research agency services. The company was founded in 1989 and is based in Hwaseong-si, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 1989
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 215380

Financial Performance

In 2023, WOOJUNG BIO's revenue was 38.62 billion, a decrease of -17.70% compared to the previous year's 46.92 billion. Losses were -5.05 billion, 168.8% more than in 2022.